- Mandela service sign language interpreter: ‘He made up his own signs’
- Pope Francis named Time’s ‘Person of the Year’
- Ben Affleck: Fundraising for Democrats started to ‘feel gross’
- Vladimir Putin orders military to boost presence in Arctic
- Brooklyn, N.Y.: ‘Lesbian capital’ of the Northeast
- Elian Gonzalez: It’s America’s fault that my mother died
- India top court rules homosexuality is illegal
- Aaron Hernandez, ex-Patriot, on prison life: ‘I’m way less stressed in jail’
- Man pulled from water believed to be disgraced D.C. cop
- Kabul airport hit by suicide bomber who targeted NATO gate
By Donald Lambro
Growth spikes are little more than trend-free anomalies
Independent voices from the The Washington Times Communities
Topic - Theresa Deisher
The Supreme Court said Monday that it would not hear a case challenging the Obama administration's guidelines on embryonic stem-cell research.
The Obama administration's expansion of stem cell research has suffered a significant setback with a judge's ruling that blocks important work on treating life-threatening conditions, say private groups pushing for scientific breakthroughs in medicine.
A federal judge on Monday temporarily blocked government rules expanding stem cell research, a blow to the Obama administration that could stall potentially lifesaving research.
Theresa Deisher of AVM Biotechnology, argue that the guidelines will result in increased competition for limited federal funding and will injure their ability to compete successfully for National Institutes of Health stem cell research money.